View 
FILTERS (0)

MORE FILTERS

  
reports
 PRESS RELEASE

DGAP-News: ACCENTRO Acquires Attractive Portfolio in Berlin

DGAP-News: Accentro Real Estate AG / Key word(s): Real Estate/Acquisition ACCENTRO Acquires Attractive Portfolio in Berlin 06.12.2021 / 08:30 The issuer is solely responsible for the content of this announcement. ACCENTRO Acquires Attractive Portfolio in Berlin - Acquisition of 73 units in sought-after locations of Berlin - Portfolio of partitioned properties, earmarked for individual sales Berlin, 6 December 2021 - ACCENTRO Real Estate AG ("ACCENTRO"), an investor in residential real estate and Germany's leading housing privatisation company, just acquired 73 already...

 PRESS RELEASE

DGAP-News: ACCENTRO erwirbt attraktives Portfolio in Berlin

DGAP-News: Accentro Real Estate AG / Schlagwort(e): Immobilien/Ankauf ACCENTRO erwirbt attraktives Portfolio in Berlin 06.12.2021 / 08:30 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. ACCENTRO erwirbt attraktives Portfolio in Berlin - Ankauf von 73 Einheiten in begehrten Lagen Berlins - Aufgeteilter Privatisierungsbestand Berlin, 6. Dezember 2021 - Die ACCENTRO Real Estate AG ("ACCENTRO"), Wohninvestor und Deutschlands führendes Wohnungsprivatisierungsunternehmen, hat von einem institutionellen Investor 73 bereits rechtlich aufgeteilte E...

 PRESS RELEASE

Opjustering af omsætning og driftsresultat

Opjustering af omsætning og driftsresultat MEDDELELSE NR. 2166. december 2021 Opjustering af omsætning og driftsresultat ChemoMetec har i 2. kvartal af regnskabsåret 2021/22 fortsat sin positive udvikling, hvor salget og ordretilgangen på især det nordamerikanske marked har udviklet sig væsentligt bedre end forventet. Samtidig har USD-kursen været stigende i de første fem måneder af regnskabsåret, ligesom den globale forsyningssituation for råvarer endnu ikke har påvirket ChemoMetecs leveringsevne vedrørende færdige produkter. ChemoMetec har således indtil videre kunnet opretholde produkt...

 PRESS RELEASE

BIC renforce son Comité Exécutif et intègre de nouvelles compétences

BIC renforce son Comité Exécutif et intègre de nouvelles compétences          POUR PUBLICATION IMMEDIATE                         BIC renforce son Comité Exécutif et intègre de nouvelles compétences afin d’accélérer la mise en œuvre de son plan Horizon Clichy, France – 6 Décembre 2021– En novembre 2020, BIC a lancé " Horizon ", un plan stratégique visant à stimuler une croissance durable à long terme et à assurer une rémunération solide des actionnaires. Centré sur les besoins des consommateurs et les exigences en matière de développement durable, ce plan capitalise sur les points forts...

 PRESS RELEASE

BIC strengthens its Executive Leadership Team through new appointments

BIC strengthens its Executive Leadership Team through new appointments FOR IMMEDIATE RELEASE                         BIC strengthens its Executive Leadership Team through new appointments New capabilities will accelerate Horizon Plan Clichy, France – December 6, 2021– In November 2020, BIC launched “Horizon,” a comprehensive plan aimed to drive sustainable growth and shareholder returns. Building on BIC’s strengths, this plan is focused on a set of organic and inorganic growth initiatives, with an increased focus on consumer needs and sustainability. To better address these strategic c...

 PRESS RELEASE

Aino Health AB (publ): Aino Health tecknar partneravtal med Pihlajalin...

Aino Health AB (publ): Aino Health tecknar partneravtal med Pihlajalinna Plc Aino Health tecknar partneravtal med Pihlajalinna Plc, en av de tre stora leverantörerna av hälso- och sjukvårdstjänster i Finland.Pihlajalinna organiserar över 200 000 anställda inom ramen för företagshälsovård.   Genom partnerskapet får Aino möjlighet att stärka Pihlajalinnas erbjudande till sina kunder inom både privat och offentlig sektor med  SaaS-lösningen HealthManager. Innan samarbetsavtalet undertecknades så tecknade Pihlajalinna 8 000 nya HealthManager-licenser under tredje kvartalet. Aino ser detta so...

 PRESS RELEASE

Déclaration d’actions et de droits de vote de la société Valneva SE - ...

Déclaration d’actions et de droits de vote de la société Valneva SE - Novembre 2021 VALNEVA Déclaration d’actions et de droits de vote 30 novembre 2021 __________________________________________________________________________________________ Dénomination sociale : VALNEVAAdresse du siège social : 6 rue Alain Bombard, 44800 Saint-HerblainMarché réglementé Euronext Paris - Compartiment B Date de la déclaration : 6 décembre 2021 Nombre d’actions composant le capital de Valneva Nombre total de droits de vote incluant les droits de vote suspend...

 PRESS RELEASE

Aino Health AB (publ): Aino Health signs partner agreement with Pihlaj...

Aino Health AB (publ): Aino Health signs partner agreement with Pihlajalinna Plc Aino Health announces that they sign partner agreement with Pihlajalinna Plc, one of the big three health and healthcare service providers in Finland. Pihlajalinna organizes over 200 000 employees in their occupational health care services.   By the partnership Aino will get the possibility to strengthen Pihlajalinna’s offer to their customers in both private and public sector with the HealthManager SaaS solution.   Before signing this co-operation agreement Pihlajalinna signed 8 000 new HealthManager lic...

 PRESS RELEASE

Valneva SE: declaration of shares and voting rights - November 2021

Valneva SE: declaration of shares and voting rights - November 2021 VALNEVA Declaration of shares and voting rights November 30, 2021 __________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment B Declaration date: December 6, 2021 Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the c...

 PRESS RELEASE

Royal Dutch Shell Plc Third Quarter 2021 Euro and GBP Equivalent Divid...

Royal Dutch Shell Plc Third Quarter 2021 Euro and GBP Equivalent Dividend Payments The Hague, December 6, 2021 - The Board of Royal Dutch Shell plc (“RDS”) today announced the pounds sterling and euro equivalent dividend payments in respect of the third quarter 2021 interim dividend, which was announced on October 28, 2021 at US$0.24 per A ordinary share (“A Share”) and B ordinary share (“B Share”). Dividends on A Shares will be paid, by default, in euros at the rate of €0.2121per A Share. Holders of A Shares who have validly submitted US dollars or pounds sterling currency elections by No...

 PRESS RELEASE

Travis Perkins: Transaction in Own Shares

Travis Perkins (TPK) Travis Perkins: Transaction in Own Shares 06-Dec-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Transactions in Own Shares     Travis Perkins plc (the "Company") announces that it has purchased the following number of its ordinary shares of 11.205105 pence each on the London Stock Exchange, from Citigroup Global Markets Limited as part of its buy-back programme announced on 21 September 2021:   Date of purchase: 3 December 202...

 PRESS RELEASE

Coinsilium Group Limited: Greengage Investment Update

Coinsilium Group Limited (COIN) Coinsilium Group Limited: Greengage Investment Update 06-Dec-2021 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. COINSILIUM GROUP LIMITED ("Coinsilium" or the "Company") Coinsilium Group Limited: Greengage Investment Update   London, UK, 6 December 2021 - Coinsilium Group Limited (AQSE: COIN) (OTCQB: CINGF), the Blockchain and Open Finance venture builder,...

 PRESS RELEASE

DGAP-News: ENCAVIS AG FÜHREND IN DER ORGANISATORISCHEN TRANSFORMATION ...

DGAP-News: ENCAVIS AG / Schlagwort(e): Sonstiges/Strategische Unternehmensentscheidung ENCAVIS AG FÜHREND IN DER ORGANISATORISCHEN TRANSFORMATION NACH DEM SUBVENTIONSENDE 06.12.2021 / 07:55 Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. ENCAVIS FÜHREND IN DER ORGANISATORISCHEN TRANSFORMATION NACH DEM SUBVENTIONSENDE Führender unabhängiger Stromerzeuger für Erneuerbare Energien arbeitet bei der Aktualisierung seines Betriebsmodells mit Pexapark zusammen, weil er trotz Auslaufens der staatlicher Förderung von Enerneuerbaren-Energien-Anlagen u...

 PRESS RELEASE

Royal KPN N.V. Press Release: KPN, APG and Glaspoort agree on extensio...

Royal KPN N.V. Royal KPN N.V. Press Release: KPN, APG and Glaspoort agree on extension fiber rollout by JV 06-Dec-2021 / 08:00 CET/CEST     KPN, APG and Glaspoort agree on extension fiber rollout by JV Rotterdam, 6 December 2021 - Today, Royal KPN N.V. (KPN) announces that KPN, APG (investing on behalf of its pension fund client ABP) and Glaspoort signed an agreement to extend the scope of the fiber rollout of the joint venture Glaspoort. All parties reassessed the scope of the JV and agreed to a limited extension of the original scope by ~170k households, which Glaspoort also ex...

 PRESS RELEASE

DGAP-News: ENCAVIS AG SPEARHEADS POST-SUBSIDY ORGANISATIONAL TRANSFORM...

DGAP-News: ENCAVIS AG / Key word(s): Miscellaneous/Strategic Company Decision ENCAVIS AG SPEARHEADS POST-SUBSIDY ORGANISATIONAL TRANSFORMATION 06.12.2021 / 07:55 The issuer is solely responsible for the content of this announcement. ENCAVIS SPEARHEADS POST-SUBSIDY ORGANISATIONAL TRANSFORMATION Leading renewable energy IPP works with Pexapark to upgrade its operating system as it seeks to double in size in the post-subsidy marketZurich/Hamburg, December 6, 2021 - Encavis AG (Encavis), SDAX-listed wind and solar park operator and one of Europe's leading Independent Power ...

 PRESS RELEASE

OKYO Pharma Limited ("OKYO" or the "Company") to File IND in Q3 2022 f...

OKYO Pharma Limited ("OKYO" or the "Company") to File IND in Q3 2022 for OK-101 to treat Dry Eye Disease ("DED") and to go directly to a Phase 2 Human Clinical Efficacy Trial in DED Patients with a planned start date in Q4 2022 on an accelerated basis LONDON, Dec. 06, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), the biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, is pleased to announce that working with Ora, Inc., a world-class ophthalmic clinical development partner, it is...

 PRESS RELEASE

Quantum Genomics Signs an Exclusive License and Production Agreement w...

Quantum Genomics Signs an Exclusive License and Production Agreement with Gulf Pharmaceuticals Industries Julphar Quantum Genomics will receive up to $20 M in upfront, development and sales milestone payments as well as royalties on future salesJulphar will receive an exclusive license to market firibastat in the Middle East, all African countries, Commonwealth of Independent States and TurkeyJulphar will be the exclusive firibastat producer in those regionsJulphar will support Quantum Genomics as a core shareholder PARIS, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Grow...

 PRESS RELEASE

ForFarmers N.V.: Update share buy-back programme ForFarmers

ForFarmers N.V.: Update share buy-back programme ForFarmers Lochem, 6 December 2021 Update share buy-back programme ForFarmers ForFarmers N.V. (ForFarmers) has repurchased 224,000 shares in the period from 2 December 2021 through 3 December 2021. The shares were repurchased at an average price of €3.73 per share, for a total amount of €835,184. These repurchases were made in accordance with the authorisation granted by the ForFarmers Annual General Meeting of Shareholders on 23 April 2021 to buy back at maximum 10% of ForFarmers shares and the share buy-back programme of at...

 PRESS RELEASE

COOPTATION DE BARBARA DALIBARD AU CONSEIL D’ADMINISTRATION DE REXEL

COOPTATION DE BARBARA DALIBARD AU CONSEIL D’ADMINISTRATION DE REXEL ___________________________________________________________________________________________ COOPTATION DE BARBARA DALIBARD AU CONSEIL D’ADMINISTRATION DE REXEL _______________________________________________________________________________________ Lors de sa réunion du 3 décembre 2021, le Conseil d’administration de Rexel a décidé à l’unanimité, sur recommandation du Comité des nominations, de coopter Barbara Dalibard en tant que membre indépendant du Conseil d’administration, à effet immédiat. Barbara Dalibard remplac...

 PRESS RELEASE

ForFarmers N.V.: Voortgang inkoopprogramma eigen aandelen ForFarmers

ForFarmers N.V.: Voortgang inkoopprogramma eigen aandelen ForFarmers Lochem, 6 december 2021 Voortgang inkoopprogramma eigen aandelen ForFarmers ForFarmers N.V. (ForFarmers) heeft in de periode van 2 december 2021 tot en met 3 december 2021 224.000 aandelen ingekocht. De aandelen zijn ingekocht met een gemiddelde prijs van €3,73 per aandeel, voor een totaalbedrag van €835.184. Deze inkopen zijn gedaan in overeenstemming met de machtiging verleend door de Algemene Vergadering van Aandeelhouders van ForFarmers op 23 april 2021 voor het inkopen van eigen aandelen tot een maximum...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch